MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 11..20 of 67 - per page Previous page Next page
Order by
Therapeutic method to treat prostate carcinomas by administration of cellular PAcP protein. More
A method for large scale production, recovery, and purification process for plasmid DNA manufacturing meeting human clinical trial requirements. More
A simple blood based assay to identify diabetic patients who are likely to develop or have early stage diabetic nephropathy has been developed at King's. This has the potential to be used regularly at diabetic clinics. More
Recently characterized MUC17 gene highly specific for pancreatic cancer. More
Diagnostic and potential therapeutic applications for mucin gene 4 (MUC4). More
Mammalian cell-based reverse two-hybrid system to screen and identify drugs having the ability to disrupt the interaction between two candidate proteins. More
Monoclonal antibody for a novel HIV protein with potential diagnostic, prognostic, and therapeutic uses. More
This rapid and precise on/off switch regulate the expression of transgenes in mammalian cells More
A method for high-throughput screening of known pathogenic viruses along with identification of "new" disease-associated viruses More
This new procedure to generate transgenic animals with exogen DNA sequences or transgenes of variable length is faster and more efficient than other approaches. We are interested in establishing license agreements with appropriate companies. More
Displaying 11..20 of 67 - per page Previous page Next page
Order by

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us